Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) reported a 34% year-over-year revenue increase Tuesday for the second quarter of fiscal 2024, to $194 million.
"Our Q2 financial results demonstrate the strength of our brands, our global team, and our diversified growth strategy," Irwin D. Simon, chairman and CEO of the Canadian cannabis giant that has been pushing to become one of the top beer and alcohol beverage companies in the U.S as well.
In the meantime, the company continues to grow its medical cannabis business in Europe and internationally.
Last month, Simon traveled to Israel and Germany as legal cannabis seems to be on the horizon.
"I went to meet with other CEOs of consumer package good companies," Simon told Fox Business in an exclusive interview.
In Germany, where the company's Europe-based business branch Tilray Europe is headquartered, he visited the Parliament to discuss cannabis, as German legalization comes closer to the finish line.
In the U.S., Tilray is looking to enter the market once cannabis is legalized on the federal level. For now, the company is growing its presence within the U.S. craft beverage-alcohol market.
"We have also emerged as a disruptor in the craft beverage-alcohol industry by assembling a portfolio of highly sought-after brands that are dominating key regions across the U.S. in the Northeast, the Pacific Northwest, and the Southeast," Simon said in a press release.
In Canada, the acquisitions of HEXO Corp. and Truss Beverage acquisitions together bolstered Tilray's cannabis presence.
The company recently debuted its new RIFF BOOST beverage collection, featuring two new ready-to-drink THC and CBG-infused drinks from premium cannabis brand, RIFF, as well as its seasonal release from its cannabis wellness brand, Solei.
Tilray's shares traded 5.56% higher at $2.47 per share during the pre-market session on Tuesday morning.